Danilo Ribeiro, Ph.D. - Related publications

2008 Chemical and Biological Engineering Polytechnic University 
Chemical Engineering
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Hachey SJ, Movsesyan S, Nguyen QH, Burton-Sojo G, Tankazyan A, Wu J, Hoang T, Zhao D, Wang S, Hatch MM, Celaya E, Gomez S, Chen GT, Davis RT, Nee K, et al. An vascularized micro-tumor model of human colorectal cancer recapitulates responses to standard-of-care therapy. Lab On a Chip. PMID 33605955 DOI: 10.1039/d0lc01216e   
2021 Ma H, Pilvankar M, Wang J, Giragossian C, Popel AS. Quantitative Systems Pharmacology Modeling of PBMC-Humanized Mouse to Facilitate Preclinical Immuno-oncology Drug Development. Acs Pharmacology & Translational Science. 4: 213-225. PMID 33615174 DOI: 10.1021/acsptsci.0c00178   
2021 Tansey W, Li K, Zhang H, Linderman SW, Rabadan R, Blei DM, Wiggins CH. Dose-response modeling in high-throughput cancer drug screenings: an end-to-end approach. Biostatistics (Oxford, England). PMID 33417699 DOI: 10.1093/biostatistics/kxaa047   
2021 Chang S. Generation of Colon Cancer Model Based on Colonoscopy Injection. Methods in Molecular Biology (Clifton, N.J.). 2224: 147-152. PMID 33606213 DOI: 10.1007/978-1-0716-1008-4_11   
2021 Hori SS, Tong L, Swaminathan S, Liebersbach M, Wang J, Gambhir SS, Felsher DW. A mathematical model of tumor regression and recurrence after therapeutic oncogene inactivation. Scientific Reports. 11: 1341. PMID 33446671 DOI: 10.1038/s41598-020-78947-2   
2021 Mapanao AK, Che PP, Sarogni P, Sminia P, Giovannetti E, Voliani V. Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation. Expert Opinion On Drug Metabolism & Toxicology. 1-22. PMID 33565346 DOI: 10.1080/17425255.2021.1879047   
2021 Li L, Wang J, Radford DC, Kopeček J, Yang J. Combination treatment with immunogenic and anti-PD-L1 polymer-drug conjugates of advanced tumors in a transgenic MMTV-PyMT mouse model of breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33607175 DOI: 10.1016/j.jconrel.2021.02.011   
2021 Jiménez-Sánchez J, Martínez-Rubio Á, Popov A, Pérez-Beteta J, Azimzade Y, Molina-García D, Belmonte-Beitia J, Calvo GF, Pérez-García VM. A mesoscopic simulator to uncover heterogeneity and evolutionary dynamics in tumors. Plos Computational Biology. 17: e1008266. PMID 33566821 DOI: 10.1371/journal.pcbi.1008266   
2021 Lee J, Lee D, Lawler S, Kim Y. Role of neutrophil extracellular traps in regulation of lung cancer invasion and metastasis: Structural insights from a computational model. Plos Computational Biology. 17: e1008257. PMID 33596197 DOI: 10.1371/journal.pcbi.1008257   
2021 Huang H, Huang Y, Chen Y, Luo Z, Zhang Z, Sun R, Wan Z, Sun J, Lu B, Zhang L, Hu J, Li S. A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death. Biomaterials. 270: 120708. PMID 33578254 DOI: 10.1016/j.biomaterials.2021.120708   
2021 Tang N, Li H, Zhang L, Zhang X, Chen Y, Shou H, Feng S, Chen X, Luo Y, Tang R, Wang B. A macromolecular drug for cancer therapy via extracellular calcification. Angewandte Chemie (International Ed. in English). PMID 33427367 DOI: 10.1002/anie.202016122   
2021 Boshuizen J, Pencheva N, Krijgsman O, D'Empaire Altimari D, Garrido Castro P, de Bruijn B, Ligtenberg MA, Gresnigt-van den Heuvel E, Vredevoogd DW, Song JY, Visser N, Apriamashvili G, Janmaat ML, Plantinga TS, Franken P, et al. Cooperative targeting of immunotherapy-resistant melanoma and lung cancer by an AXL-targeting antibody-drug conjugate and immune checkpoint blockade. Cancer Research. PMID 33531370 DOI: 10.1158/0008-5472.CAN-20-0434   
2021 Zhang B, Tang C, Yao Y, Chen X, Zhou C, Wei Z, Xing F, Chen L, Cai X, Zhang Z, Sun S, Liu Q. The tumor therapy landscape of synthetic lethality. Nature Communications. 12: 1275. PMID 33627666 DOI: 10.1038/s41467-021-21544-2   
2021 Shenoy GN, Greene CJ, Bhatta M, Baroja ML, Loyall JL, Balu-Iyer SV, Kelleher RJ, Carreno BM, Linette GP, Shultz LD, Bankert RB. Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform. Clinical & Translational Immunology. 10: e1246. PMID 33552509 DOI: 10.1002/cti2.1246   
2021 Kumar A, Patel S, Bhatkar D, Sarode SC, Sharma NK. A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death. Metabolomics : Official Journal of the Metabolomic Society. 17: 3. PMID 33389242 DOI: 10.1007/s11306-020-01755-2   
2021 Valente LJ, Attardi LD. P53 orchestrates a complex symphony of cellular processes during oncosuppression. Molecular & Cellular Oncology. 8: 1852066. PMID 33553606 DOI: 10.1080/23723556.2020.1852066   
2021 Abreu TR, Biscaia M, Gonçalves N, Fonseca NA, Moreira JN. In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles. Advances in Experimental Medicine and Biology. 1295: 271-299. PMID 33543464 DOI: 10.1007/978-3-030-58174-9_12   
2021 Vakil V, Trappe W. Dosage strategies for delaying resistance emergence in heterogeneous tumors. Febs Open Bio. PMID 33638275 DOI: 10.1002/2211-5463.13129   
2021 Guerreiro N, Jullion A, Ferretti S, Fabre C, Meille C. Translational Modeling of Anticancer Efficacy to Predict Clinical Outcomes in a First-in-Human Phase 1 Study of MDM2 Inhibitor HDM201. The Aaps Journal. 23: 28. PMID 33554304 DOI: 10.1208/s12248-020-00551-z   
2021 Zhang M, Cai H, Du Y, Wang Y, Gong J, Xu J, Liu X. Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug Combination. Molecular Pharmaceutics. PMID 33471533 DOI: 10.1021/acs.molpharmaceut.0c01203   
2021 Zeng Z, Yang B, Liao Z. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer. Future Oncology (London, England). PMID 33397136 DOI: 10.2217/fon-2020-0829   
2021 Wei T, Li M, Zhu Z, Xiong H, Shen H, Zhang H, Du Q, Li Q. Vincristine upregulates PD-L1 and increases the efficacy of PD-L1 blockade therapy in diffuse large B-cell lymphoma. Journal of Cancer Research and Clinical Oncology. PMID 33389078 DOI: 10.1007/s00432-020-03446-w   
2021 Konen JM, Rodriguez BL, Padhye A, Ochieng JK, Gibson L, Diao L, Fowlkes NW, Fradette JJ, Peng DH, Cardnell RJ, Kovacs JJ, Wang J, Byers LA, Gibbons DL. Dual inhibition of MEK and AXL targets tumor cell heterogeneity and prevents resistant outgrowth mediated by the epithelial-to-mesenchymal transition in NSCLC. Cancer Research. PMID 33402388 DOI: 10.1158/0008-5472.CAN-20-1895   
2021 Oshimori N, Guo Y, Taniguchi S. An emerging role for cellular crosstalk in the cancer stem cell niche microenvironment. The Journal of Pathology. PMID 33634866 DOI: 10.1002/path.5655   
2021 Viticchié G, Powley I, Demetriou C, Cooper J, Butterworth M, Patel M, Abid N, Miles G, Howells L, Pringle H, MacFarlane M, Pritchard C. Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients. Journal of Visualized Experiments : Jove. PMID 33616105 DOI: 10.3791/62130   
2021 Augustine R, Kalva SN, Ahmad R, Zahid AA, Hasan S, Nayeem A, McClements L, Hasan A. 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy. Translational Oncology. 14: 101015. PMID 33493799 DOI: 10.1016/j.tranon.2021.101015   
2021 Fu L, Li S, Xiao W, Yu K, Li S, Yuan S, Shen J, Dong X, Fang Z, Zhang J, Chen S, Li W, You H, Xia X, Kang T, et al. DGKA Mediates Resistance to PD-1 Blockade. Cancer Immunology Research. PMID 33608256 DOI: 10.1158/2326-6066.CIR-20-0216   
2021 Yang Z, Zhao L, Wang X, He Z, Wang Y. Ratiometric Delivery of Mitoxantrone and Berberine Co-encapsulated Liposomes to Improve Antitumor Efficiency and Decrease Cardiac Toxicity. Aaps Pharmscitech. 22: 46. PMID 33442785 DOI: 10.1208/s12249-020-01910-x   
2021 Li J, Qi D, Hsieh TC, Huang JH, Wu JM, Wu E. Trailblazing perspectives on targeting breast cancer stem cells. Pharmacology & Therapeutics. 107800. PMID 33421449 DOI: 10.1016/j.pharmthera.2021.107800   
2021 Simonaggio A, Epaillard N, Pobel C, Moreira M, Oudard S, Vano YA. Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC). Cancers. 13. PMID 33435262 DOI: 10.3390/cancers13020231   
2021 Fernando K, Kwang LG, Lim JTC, Fong ELS. Hydrogels to engineer tumor microenvironments . Biomaterials Science. PMID 33438702 DOI: 10.1039/d0bm01943g   
2021 Zou ZV, Le Gal K, El Zowalaty AE, Pehlivanoglu LE, Garellick V, Gul N, Ibrahim MX, Bergh PO, Henricsson M, Wiel C, Akyürek LM, Bergo MO, Sayin VI, Lindahl P. Antioxidants Promote Intestinal Tumor Progression in Mice. Antioxidants (Basel, Switzerland). 10. PMID 33557356 DOI: 10.3390/antiox10020241   
2021 Li X, Su X, Liu R, Pan Y, Fang J, Cao L, Feng C, Shang Q, Chen Y, Shao C, Shi Y. HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression. Oncogene. PMID 33564072 DOI: 10.1038/s41388-020-01636-x   
2021 Lu Y, Jia D, Ma X, Liang M, Hou S, Qiu W, Gao Y, Xue P, Kang Y, Xu Z. Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy. Acs Applied Materials & Interfaces. PMID 33565847 DOI: 10.1021/acsami.0c21710   
2021 Castelli V, Giordano A, Benedetti E, Giansanti F, Quintiliani M, Cimini A, d'Angelo M. The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death. Cancers. 13. PMID 33477367 DOI: 10.3390/cancers13020328   
2021 Boutelle AM, Attardi LD. p53 and Tumor Suppression: It Takes a Network. Trends in Cell Biology. PMID 33518400 DOI: 10.1016/j.tcb.2020.12.011   
2021 Li L, Wei JR, Dong J, Lin QG, Tang H, Jia YX, Tan W, Chen QY, Zeng TT, Xing S, Qin YR, Zhu YH, Li Y, Guan XY. Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy. Science Advances. 7. PMID 33536206 DOI: 10.1126/sciadv.abc8346   
2021 Xiong W, Qi L, Jiang N, Zhao Q, Chen L, Jiang X, Li Y, Zhou Z, Shen J. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. Acs Applied Materials & Interfaces. PMID 33577301 DOI: 10.1021/acsami.0c21743   
2021 Xiong W, Qi L, Jiang N, Zhao Q, Chen L, Jiang X, Li Y, Zhou Z, Shen J. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. Acs Applied Materials & Interfaces. PMID 33577301 DOI: 10.1021/acsami.0c21743   
2021 Lee JY, Chaudhuri O. Modeling the tumor immune microenvironment for drug discovery using 3D culture. Apl Bioengineering. 5: 010903. PMID 33564739 DOI: 10.1063/5.0030693   
2021 Saini H, Nikkhah M. Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression. Methods in Molecular Biology (Clifton, N.J.). 2258: 241-255. PMID 33340365 DOI: 10.1007/978-1-0716-1174-6_16   
2021 Vaidya KS, Mitten MJ, Zelaya-Lazo AL, Oleksijew A, Alvey C, Falls HD, Mishra S, Palma J, Ansell P, Phillips AC, Reilly EB, Anderson M, Boghaert ER. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR. Journal of Neuro-Oncology. PMID 33517558 DOI: 10.1007/s11060-021-03703-z   
2021 Samara B, Deliorman M, Sukumar P, Qasaimeh MA. Cryopreservable arrays of paper-based 3D tumor models for high throughput drug screening. Lab On a Chip. PMID 33615319 DOI: 10.1039/d0lc01300e   
2021 Lamballe F, Ahmad F, Vinik Y, Castellanet O, Daian F, Müller AK, Köhler UA, Bailly AL, Josselin E, Castellano R, Cayrou C, Charafe-Jauffret E, Mills GB, Géli V, Borg JP, et al. Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2003049. PMID 33552868 DOI: 10.1002/advs.202003049   
2021 Colin F, Schauer K, Hamiche A, Martineau P, Borg JP, Bednar J, Bertolin G, Camoin L, Collette Y, Dimitrov S, Fournier I, Hyenne V, Mendoza-Parra MA, Morelli X, Rondé P, et al. The NANOTUMOR consortium - towards the Tumor Cell Atlas. Biology of the Cell. PMID 33554340 DOI: 10.1111/boc.202000135   
2021 Pham TND, Shields MA, Spaulding C, Principe DR, Li B, Underwood PW, Trevino JG, Bentrem DJ, Munshi HG. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. Cancers. 13. PMID 33503832 DOI: 10.3390/cancers13030440   
2021 Blagoev KB, Iordanov R, Zhou M, Fojo T, Bates SE. Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer. Oncotarget. 12: 15-21. PMID 33456710 DOI: 10.18632/oncotarget.27855   
2021 Yan S, Wan G. Tumor-associated macrophages in immunotherapy. The Febs Journal. PMID 33492779 DOI: 10.1111/febs.15726   
2021 Deng L, Wu X, Zhu X, Yu Z, Liu Z, Wang J, Zheng Y. Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma. American Journal of Translational Research. 13: 57-72. PMID 33527008   
2021 Saleh NA, Rode MP, Sierra JA, Silva AH, Miyake JA, Filippin-Monteiro FB, Creczynski-Pasa TB. Three-dimensional multicellular cell culture for anti-melanoma drug screening: focus on tumor microenvironment. Cytotechnology. 73: 35-48. PMID 33505112 DOI: 10.1007/s10616-020-00440-5